Yahoo

Has Ovintiv (OVV) Become Expensive After Its Logan Energy Deal?

Trade Ovintiv on Coinbase

Ovintiv (OVV) just moved to expand its Montney footprint by agreeing to buy Canadian producer Logan Energy in an all-cash deal worth about C$1.26 billion, or roughly US$890 million including net debt.

That Logan deal lands after a powerful run in Ovintiv's share price, with a 30‑day share price return of 18.29% and a year to date share price gain of 75.67%. The 1 year total shareholder return of 98.77% points to strong longer term momentum.

Spot 29 high quality undervalued stocks that, like Ovintiv after the Logan deal, already show strong execution but still trade at prices that do not fully reflect their fundamentals.

Ovintiv now trades at $71.13, compared with an analyst target of about $80.78 and an implied intrinsic value gap of roughly 48%. After the Logan move, where does fair value really sit in that spread?

Most Popular Narrative: 9% Undervalued

Ovintiv's most followed narrative points to a fair value of about $78.29 using a 7.24% discount rate, compared with the last close at $71.13. That gap frames the Logan deal and the wider Montney build out as key tests of whether the current discount holds.

Realization of full cost and productivity benefits from the NuVista and Paramount Montney acquisitions, where Ovintiv is targeting around US$100 million of annualized free cash flow synergies and has already reached planned per well D&C savings on initial pads, can lower unit costs further and support higher free cash flow and earnings per share. Continuation of the balance sheet and capital return framework, with net debt near US$3.0b, leverage at roughly 0.6x, expected annualized interest savings of about US$80 million, and a commitment to return at least 60% of 2026 free cash flow via buybacks and dividends, can keep reducing financing costs and shrinking the share count.

See why 12 investors see Ovintiv as 9% undervalued .

Result: Fair Value of $78.29 (UNDERVALUED)

Still, the narrative can unravel if Ovintiv faces fresh non cash impairments or if insider selling and cautious third party valuations begin to carry more weight with investors.

Find out about the key risks to this Ovintiv narrative .

Next Steps

Mixed signals like this can feel messy, so move fast, review the data yourself, and weigh 3 key rewards and 2 important warning signs .

Looking for more Ovintiv-sized opportunities?

Do not stop at a single idea. Use the Simply Wall Street Screener to scan for other stocks where the numbers and story line up before the crowd catches on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OVV .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: